BioLife Solutions, Inc.

NasdaqCM:BLFS Stock Report

Market Cap: US$1.2b

BioLife Solutions Future Growth

Future criteria checks 4/6

BioLife Solutions is forecast to grow earnings and revenue by 72.5% and 15.2% per annum respectively. EPS is expected to grow by 73% per annum. Return on equity is forecast to be -4% in 3 years.

Key information

72.5%

Earnings growth rate

73.0%

EPS growth rate

Life Sciences earnings growth17.8%
Revenue growth rate15.2%
Future return on equity-4.0%
Analyst coverage

Good

Last updated15 Aug 2024

Recent future growth updates

Recent updates

Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

Aug 14
Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Jun 20
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Jun 05
A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

May 14
Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

May 13
Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

May 11
Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

Mar 12
Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

Feb 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Dec 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Aug 17
Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Aug 11
Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

May 06
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Feb 22
Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Jan 10
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

Dec 10
Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

BioLife: What The Future Holds

Oct 19

BioLife Solutions COO Roderick de Greef to retire

Oct 03

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Sep 27
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

BioLife Solutions GAAP EPS of -$1.71 misses by $1.50, revenue of $40.5M beats by $1.33M

Aug 09

BioLife Solutions: Sell-Side Posture Overly Optimistic, Rate Neutral

Jul 29

Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Jun 15
Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Earnings and Revenue Growth Forecasts

NasdaqCM:BLFS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026155811253
12/31/2025119-11-6148
12/31/2024110-26-789
6/30/2024140-64-80N/A
3/31/2024141-62-22-14N/A
12/31/2023143-66-24-12N/A
9/30/2023136-93-22-7N/A
6/30/2023143-74-17-1N/A
3/31/2023155-141-19-3N/A
12/31/2022162-140-22-8N/A
9/30/2022155-106-28-17N/A
6/30/2022148-96-27-17N/A
3/31/2022139-15-27-14N/A
12/31/2021119-9-19-5N/A
9/30/2021975-19-2N/A
6/30/2021744-19-4N/A
3/31/202153-20-38N/A
12/31/2020482-17N/A
9/30/202042703N/A
6/30/2020371615N/A
3/31/20203439-31N/A
12/31/201927-2-11N/A
9/30/201925-3223N/A
6/30/201923-3922N/A
3/31/201922-4423N/A
12/31/201820-2522N/A
9/30/201817123N/A
6/30/201815022N/A
3/31/201812-2N/A1N/A
12/31/201711-3N/A1N/A
9/30/201710-5N/A-1N/A
6/30/20179-6N/A-2N/A
3/31/20179-7N/A-3N/A
12/31/20168-7N/A-4N/A
9/30/20168-5N/A-5N/A
6/30/20167-5N/A-5N/A
3/31/20167-4N/A-5N/A
12/31/20156-4N/A-5N/A
9/30/20156-4N/A-4N/A
6/30/20156-4N/A-4N/A
3/31/20156-4N/A-4N/A
12/31/20146-3N/A-3N/A
9/30/20147-3N/A-2N/A
6/30/20148-2N/A-2N/A
3/31/20149-2N/A-1N/A
12/31/20139-1N/A0N/A
9/30/20139-1N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BLFS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).

Earnings vs Market: BLFS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BLFS is expected to become profitable in the next 3 years.

Revenue vs Market: BLFS's revenue (15.2% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: BLFS's revenue (15.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BLFS is forecast to be unprofitable in 3 years.


Discover growth companies